Neuroleptic Malignant Syndrome with ziprasidone.
Murty
Radhika G
RG
Mistry
Sandeep G
SG
Chacko
Ranjit C
RC
D000341:Affective Disorders, Psychotic / Q000188:drug therapy*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D018492:Dopamine Antagonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology* / Q000628:therapy; D010879:Piperazines / Q000009:adverse effects*; D012702:Serotonin Antagonists / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D010879:Piperazines; D012702:Serotonin Antagonists; D013844:Thiazoles; C092292:ziprasidone